nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cutaneous CpG adjuvant conditioning to enhance vaccine responses
|
Carlow, Douglas A. |
|
|
40 |
10 |
p. 1385-1389 |
artikel |
2 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
10 |
p. IFC |
artikel |
3 |
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial
|
Thomas, Stephen J. |
|
|
40 |
10 |
p. 1483-1492 |
artikel |
4 |
Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants
|
Hu, Siyuan |
|
|
40 |
10 |
p. 1439-1447 |
artikel |
5 |
Italy’s rollout of COVID-19 vaccinations: The crucial contribution of the first experimental mass vaccination site in Lombardy
|
Oliani, Francesco |
|
|
40 |
10 |
p. 1397-1403 |
artikel |
6 |
Looking ahead: Caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model
|
Ellithorpe, Morgan E. |
|
|
40 |
10 |
p. 1404-1412 |
artikel |
7 |
MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly
|
Gorse, Geoffrey J. |
|
|
40 |
10 |
p. 1472-1482 |
artikel |
8 |
Multi-attribute characterization of pneumococcal conjugate vaccine by Size-exclusion chromatography coupled with UV-MALS-RI detections
|
Deng, James Z. |
|
|
40 |
10 |
p. 1464-1471 |
artikel |
9 |
Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
|
Sexson Tejtel, S. Kristen |
|
|
40 |
10 |
p. 1499-1511 |
artikel |
10 |
Pediatric primary care immunization policies in New York State
|
Lillvis, Denise F. |
|
|
40 |
10 |
p. 1458-1463 |
artikel |
11 |
Potent adjuvant effect elicited for tumor immunotherapy by a liposome conjugated pH-sensitive polymer and dendritic cell-targeting Toll-like-receptor ligand
|
Watanabe, Shunichi |
|
|
40 |
10 |
p. 1448-1457 |
artikel |
12 |
Safety and immunogenicity of an investigational quadrivalent meningococcal tetanus toxoid conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in infants and toddlers: A Phase II study
|
Cornish, Matthew J. |
|
|
40 |
10 |
p. 1421-1438 |
artikel |
13 |
Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring
|
Lai, Francisco Tsz Tsun |
|
|
40 |
10 |
p. 1390-1396 |
artikel |
14 |
Spatiotemporal distributions of immunization coverage in Ethiopia from 2000 to 2019
|
Asmare Atalell, Kendalem |
|
|
40 |
10 |
p. 1413-1420 |
artikel |
15 |
Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in England
|
Ladhani, Shamez N |
|
|
40 |
10 |
p. 1493-1498 |
artikel |